Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus
Tina Hennerici(Philipps University of Marburg), Rüdiger Eming(Philipps University of Marburg), Michael Hertl(Universitätsklinikum Gießen und Marburg), Kamran Ghoreschi(National Institutes of Health), Robert Pollmann(Philipps University of Marburg), Christian Möbs(Philipps University of Marburg), Maria Seipelt(Philipps University of Marburg), Thomas Schmidt(Philipps University of Marburg), Björn Tackenberg(Universitätsklinikum Gießen und Marburg)
Cited by 73
Related Papers
Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
|The Journal of Immunology|2011|634
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|597
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|379
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332